I can start, and then we’ll see who would care to comment as well.
First, I'll say that we all want this to happen as quickly as possible. But I do understand, and the MS Society does understand, that a process to get good information must be followed. We've been pushing to get as much information as possible, to get a clinical trial started as soon as possible. It's interesting. I mentioned in my remarks that Dr. Zamboni's paper was published in late 2009. There were then media pick-up of that. But even the week after that, we realized that there was something we immediately needed to look into concerning this possible treatment. So we launched our own request for proposals to look at the relationship between CCSVI and MS. We were the first organization in the world to issue a request for research proposals on CCSVI and MS and that possible relationship.
Research does take time. I understand, from conversations—our research department is working closely with CIHR on this clinical trial process—that for research in Canada, this is lightning speed. The government has responded quickly to pressure from people with MS, and thank goodness for that. Thank you all for listening. I'm sure you've all had people with MS in your offices saying that we need to find out answers about this right now. That things have moved ahead as quickly as possible I think is because of the widespread understanding of parliamentarians that this was an important issue.